IL150479A0 - Treatment of psoriasis - Google Patents

Treatment of psoriasis

Info

Publication number
IL150479A0
IL150479A0 IL15047901A IL15047901A IL150479A0 IL 150479 A0 IL150479 A0 IL 150479A0 IL 15047901 A IL15047901 A IL 15047901A IL 15047901 A IL15047901 A IL 15047901A IL 150479 A0 IL150479 A0 IL 150479A0
Authority
IL
Israel
Prior art keywords
psoriasis
treatment
Prior art date
Application number
IL15047901A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL150479A0 publication Critical patent/IL150479A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL15047901A 2000-03-07 2001-02-20 Treatment of psoriasis IL150479A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18750800P 2000-03-07 2000-03-07
PCT/US2001/005260 WO2001066101A2 (fr) 2000-03-07 2001-02-20 Traitement du psoriasis

Publications (1)

Publication Number Publication Date
IL150479A0 true IL150479A0 (en) 2002-12-01

Family

ID=22689272

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15047901A IL150479A0 (en) 2000-03-07 2001-02-20 Treatment of psoriasis

Country Status (19)

Country Link
US (1) US6683114B2 (fr)
EP (1) EP1267859A2 (fr)
JP (1) JP2003525899A (fr)
KR (1) KR20020081403A (fr)
CN (1) CN1407890A (fr)
AU (1) AU4529101A (fr)
BR (1) BR0108980A (fr)
CA (1) CA2400571A1 (fr)
DZ (1) DZ3282A1 (fr)
EA (1) EA200200948A1 (fr)
HR (1) HRP20020729A2 (fr)
HU (1) HUP0204551A2 (fr)
IL (1) IL150479A0 (fr)
MX (1) MXPA02008659A (fr)
NO (1) NO20024236D0 (fr)
PL (1) PL357042A1 (fr)
SK (1) SK12812002A3 (fr)
WO (1) WO2001066101A2 (fr)
ZA (1) ZA200205266B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL139975A0 (en) * 2000-11-29 2002-02-10 Univ Ramot Anti proliferative drugs
US20050013853A1 (en) * 2000-11-29 2005-01-20 Irit Gil-Ad Anti-proliferative drugs
CN2559015Y (zh) * 2002-04-29 2003-07-02 谢基生 电动式双层近红外滤光型防盗摄影监控装置
US20040229849A1 (en) * 2002-09-24 2004-11-18 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
WO2004075902A1 (fr) * 2003-02-28 2004-09-10 Amedis Pharmaceuticals Ltd. Utilisation de derives de silicium de venlafaxine permettant de traiter ou de prevenir le psoriasis ou un trouble panique
WO2005011583A2 (fr) * 2003-07-28 2005-02-10 Leslie Joe Dunaway Traitement de la rhinite allergique et de l'asthme
WO2007146796A2 (fr) * 2006-06-13 2007-12-21 Ramot At Tel-Aviv University Ltd. Composés antiprolifératifs, compositions contenant ceux-ci et procédés d'utilisation de ceux-ci
US20080081067A1 (en) * 2006-10-03 2008-04-03 Gupta Manishkumar Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
US20100069389A1 (en) * 2008-09-06 2010-03-18 Bionevia Pharmaceuticals, Inc. Novel forms of reboxetine
US9326935B2 (en) * 2013-11-08 2016-05-03 Eli Lilly And Company Atomoxetine solution

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU183323B (en) * 1981-02-11 1984-04-28 Richter Gedeon Vegyeszet Process for producing 17,18-dihydro-apovincaminol-3-comma down comma aaove-4-comma down comma above-5-comma down comma aaove-trimethoxy-benzoate and acid additional salts thereof
CA2134038C (fr) * 1994-06-16 1997-06-03 David Taiwai Wong Potentialisation des effets de medicaments
US5508276A (en) * 1994-07-18 1996-04-16 Eli Lilly And Company Duloxetine enteric pellets
US5658590A (en) * 1995-01-11 1997-08-19 Eli Lilly And Company Treatment of attention-deficit/hyperactivity disorder
US6150396A (en) * 1997-03-07 2000-11-21 Eli Lilly And Company Methods of treating or preventing interstitial cystitis
US5916910A (en) * 1997-06-04 1999-06-29 Medinox, Inc. Conjugates of dithiocarbamates with pharmacologically active agents and uses therefore
ZA985765B (en) * 1997-07-02 1999-08-04 Merck & Co Inc Polymorphic form of a tachykinin receptor antagonist.
UA56257C2 (uk) * 1997-09-23 2003-05-15 Елі Ліллі Енд Компані Спосіб лікування неадекватної визивної поведінки
EP1069900B1 (fr) * 1998-04-09 2005-08-10 Pharmacia & Upjohn Company LLC Nouveaux traitements avec "reboxetine" pour troubles nerveux
US6197828B1 (en) * 1998-12-01 2001-03-06 Sepracor, Inc. Derivatives of (+)-venlafaxine and methods of preparing and using the same
US6342533B1 (en) * 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
US6403645B2 (en) * 2000-03-16 2002-06-11 President And Fellows Of Harvard College Antidepressant effect of norepinephrine uptake 2 inhibitors and combined medications including them

Also Published As

Publication number Publication date
WO2001066101A2 (fr) 2001-09-13
MXPA02008659A (es) 2003-02-24
WO2001066101A3 (fr) 2002-02-07
NO20024236L (no) 2002-09-05
HRP20020729A2 (en) 2004-02-29
EA200200948A1 (ru) 2003-02-27
SK12812002A3 (sk) 2003-08-05
US20030045585A1 (en) 2003-03-06
BR0108980A (pt) 2003-06-03
DZ3282A1 (fr) 2001-09-13
HUP0204551A2 (hu) 2003-06-28
JP2003525899A (ja) 2003-09-02
CA2400571A1 (fr) 2001-09-13
AU4529101A (en) 2001-09-17
PL357042A1 (en) 2004-07-12
US6683114B2 (en) 2004-01-27
ZA200205266B (en) 2003-10-01
EP1267859A2 (fr) 2003-01-02
CN1407890A (zh) 2003-04-02
NO20024236D0 (no) 2002-09-05
KR20020081403A (ko) 2002-10-26

Similar Documents

Publication Publication Date Title
GB0007193D0 (en) Treatment of movrmrnt disorders
GB0014969D0 (en) Novel method of treatment
GB2393202B (en) Methods of well treatment
IL151132A0 (en) Pteridine compounds for the treatment of psoriasis
AU5464601A (en) Treatment of scale
EP1368024A4 (fr) Traitement de la restenose
HRP20020729A2 (en) Treatment of psoriasis
AU5000001A (en) Treatment of vitiligo
GB0124124D0 (en) Methods of treatment
GB2360453B (en) Treatment of skin conditions
AU9402401A (en) Treatment of cancers
IL154011A0 (en) Treatment of wounds
AU2001261324A1 (en) Psoriasis treatment
GB0008921D0 (en) Method of treatment
GB0101146D0 (en) Treatment of skin conditions
IL161630A0 (en) Methods of treating endometreosis
EP1303281A4 (fr) Methodes de traitement
GB0127006D0 (en) Treatment of moccasion seam
AU6191201A (en) Treatment of effluent
GB0013928D0 (en) Methods of treatment
GB0014904D0 (en) Methods of treatment
GB0008161D0 (en) Treatment of cancer
EP1158991A4 (fr) Traitement de l'asthme
TJ99000555A (en) Method of treatment of psoriasis
GB0026742D0 (en) Novel method of treatment